Active surveillance as a successful management strategy for patients with clinical stage I germ cell testicular cancer

ConclusionsThe clinical outcomes of patients with CSI GCTC managed by AS in this series were excellent. This strategy limited the administration of active treatments specifically to the minority of patients who relapsed without compromising performance.

http://link.springer.com/10.1007/s12094-018-1990-5

Source: Clinical and Translational Oncology - May 15, 2019 Category: Cancer & Oncology Source Type: research